Brokerages Anticipate Kindred Healthcare, Inc. (KND) to Announce $0.16 Earnings Per Share

Equities research analysts predict that Kindred Healthcare, Inc. (NYSE:KND) will report earnings of $0.16 per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Kindred Healthcare’s earnings, with the highest EPS estimate coming in at $0.23 and the lowest estimate coming in at $0.00. Kindred Healthcare posted earnings per share of $0.08 during the same quarter last year, which suggests a positive year-over-year growth rate of 100%. The company is scheduled to announce its next quarterly earnings results on Monday, February 26th.

According to Zacks, analysts expect that Kindred Healthcare will report full year earnings of $0.27 per share for the current year, with EPS estimates ranging from $0.12 to $0.35. For the next financial year, analysts anticipate that the business will post earnings of $0.65 per share, with EPS estimates ranging from $0.54 to $0.71. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that follow Kindred Healthcare.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.08. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same quarter last year, the business earned $0.05 earnings per share. The business’s revenue for the quarter was down 5.5% on a year-over-year basis.

A number of research analysts recently commented on KND shares. Bank of America lowered their price objective on shares of Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a research note on Thursday, September 21st. Royal Bank Of Canada reiterated a “sector perform” rating and set a $8.50 price objective (up previously from $7.50) on shares of Kindred Healthcare in a research note on Thursday, November 9th. Zacks Investment Research upgraded shares of Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Tuesday, September 19th. Deutsche Bank lowered their price objective on shares of Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, August 7th. Finally, ValuEngine upgraded shares of Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $8.86.

Kindred Healthcare (KND) opened at $7.45 on Friday. Kindred Healthcare has a 12 month low of $5.50 and a 12 month high of $11.90. The company has a current ratio of 1.55, a quick ratio of 1.53 and a debt-to-equity ratio of 6.22. The company has a market cap of $647.65, a P/E ratio of 38.25 and a beta of 1.11.

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. grew its position in Kindred Healthcare by 0.3% in the second quarter. BlackRock Inc. now owns 10,808,864 shares of the health services provider’s stock worth $125,923,000 after buying an additional 29,673 shares during the last quarter. Vanguard Group Inc. grew its position in Kindred Healthcare by 8.6% in the second quarter. Vanguard Group Inc. now owns 8,031,919 shares of the health services provider’s stock worth $93,572,000 after buying an additional 635,000 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Kindred Healthcare by 5.6% in the second quarter. Dimensional Fund Advisors LP now owns 6,004,440 shares of the health services provider’s stock worth $69,952,000 after buying an additional 315,752 shares during the last quarter. JPMorgan Chase & Co. grew its position in Kindred Healthcare by 69.8% in the third quarter. JPMorgan Chase & Co. now owns 3,572,684 shares of the health services provider’s stock worth $24,830,000 after buying an additional 1,468,066 shares during the last quarter. Finally, Glenview Capital Management LLC grew its position in Kindred Healthcare by 18.8% in the second quarter. Glenview Capital Management LLC now owns 2,374,713 shares of the health services provider’s stock worth $27,665,000 after buying an additional 375,000 shares during the last quarter. Hedge funds and other institutional investors own 89.76% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Brokerages Anticipate Kindred Healthcare, Inc. (KND) to Announce $0.16 Earnings Per Share” was reported by Week Herald and is the property of of Week Herald. If you are accessing this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The original version of this article can be accessed at https://weekherald.com/2017/12/11/brokerages-anticipate-kindred-healthcare-inc-knd-to-announce-0-16-earnings-per-share.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply